Company / AR per Share
CRISPR Therapeutics AG AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
-
FY2025
5-year range
$0.00 / $2.55
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#115 of 115
Health Care
What the data says
Declined from $2.55 to $0.00 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 115
▼
Key checks
Key Insights
- In FY2025, ar per share decreased 100.0% year-over-year.
- Peak ar per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -100.0% |
| FY2024 | $0.31 | -87.7% |
| FY2023 | $2.55 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.00 | +74.2% |
| FY2020 | $0.00 | +24.1% |
| FY2019 | $0.00 | -11.9% |
| FY2018 | $0.00 | -96.7% |
| FY2017 | $0.07 | -88.4% |
| FY2016 | $0.57 | +748.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026